Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis

被引：0
|
作者：
Kaulen, Leon D. [1 ,2 ,3 ,4 ]
Karschnia, Philipp [1 ,5 ,6 ]
Doubrovinskaia, Sofia [2 ,3 ,4 ]
Abramson, Jeremy S. [7 ]
Martinez-Lage, Maria [8 ]
Shankar, Ganesh [9 ]
Choi, Bryan D. [9 ]
Barnes, Jeffrey A. [7 ]
El-Jawahri, Areej [7 ]
Hochberg, Ephraim P. [7 ]
Johnson, P. Connor [7 ]
Soumerai, Jacob D. [7 ]
Wick, Wolfgang [2 ,3 ,4 ]
Maus, Marcela V. [7 ,10 ]
Chen, Yi-Bin [7 ]
Frigault, Matthew J. [7 ,10 ]
Dietrich, Jorg [1 ]
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Div Neurooncol, Dept Neurol,Canc Ctr, 55 Fruit St,Yawkey 9E, Boston, MA 02114 USA
[2] Heidelberg Univ, Dept Neurol, Univ Hosp Heidelberg, Heidelberg, Germany
[3] German Consortium Translat Canc Res DKTK, Clin Cooperat Unit Neurooncol, Heidelberg, Germany
[4] German Consortium Translat Canc Res DKTK, Heidelberg, Germany
[5] Ludwig Maximilians Univ LMU, Dept Neurosurg, Munich, Germany
[6] Friedrich Alexander Univ Erlangen Nuernberg, Dept Neurosurg, Erlangen, Germany
[7] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Hematol & Oncol Div,Canc Ctr, Boston, MA USA
[8] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Div Neuropathol, Boston, MA USA
[9] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA USA
[10] Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Dept Med, Cellular Immunotherapy Program, Boston, MA USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2024年 / 99卷 / 12期
关键词：
PRIMARY CNS LYMPHOMA;
D O I：
10.1002/ajh.27505
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2411 / 2415
页数：5
相关论文
共 50 条
  • [1] TOXICITIES AND OUTCOME AFTER CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR NEUROLYMPHOMATOSIS
    Kaulen, Leon D.
    Karschnia, Philipp
    Doubrovinskaia, Sofia
    Wick, Wolfgang
    Martinez-Lage, Maria
    Shankar, Ganesh
    Abramson, Jeremy S.
    Frigault, Matthew J.
    Dietrich, Jorg
    NEURO-ONCOLOGY, 2024, 26
  • [2] The treatment of follicular lymphoma with CD19-directed chimeric antigen receptor T-cell therapy
    Jacobs, Ryan
    Jacobson, Caron
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [3] Gastric adenocarcinoma following CD19-directed chimeric antigen receptor T cell therapy
    James A. Davis
    Jagoda Misniakiewicz
    Lindsey Hendrickson
    Mary McGann
    Amanda Herbst
    Brian T. Hess
    Annals of Hematology, 2023, 102 : 461 - 462
  • [4] Durable preservation of antiviral antibodies after CD19-directed chimeric antigen receptor T-cell immunotherapy
    Hill, Joshua A.
    Krantz, Elizabeth M.
    Hay, Kevin A.
    Dasgupta, Sayan
    Stevens-Ayers, Terry
    Bender Ignacio, Rachel A.
    Bar, Merav
    Maalouf, Joyce
    Cherian, Sindhu
    Chen, Xueyan
    Pepper, Greg
    Riddell, Stanley R.
    Maloney, David G.
    Boeckh, Michael J.
    Turtle, Cameron J.
    BLOOD ADVANCES, 2019, 3 (22) : 3590 - 3601
  • [5] Gastric adenocarcinoma following CD19-directed chimeric antigen receptor T cell therapy
    Davis, James A.
    Misniakiewicz, Jagoda
    Hendrickson, Lindsey
    McGann, Mary
    Herbst, Amanda
    Hess, Brian T.
    ANNALS OF HEMATOLOGY, 2023, 102 (02) : 461 - 462
  • [6] Glial injury in neurotoxicity after pediatric CD19-directed chimeric antigen receptor T cell therapy
    Gust, Juliane
    Finney, Olivia C.
    Li, Daniel
    Brakke, Hannah M.
    Hicks, Roxana M.
    Futrell, Robert B.
    Gamble, Danielle N.
    Rawlings-Rhea, Stephanie D.
    Khalatbari, Hedieh K.
    Ishak, Gisele E.
    Duncan, Virginia E.
    Hevner, Robert F.
    Jensen, Michael C.
    Park, Julie R.
    Gardner, Rebecca A.
    ANNALS OF NEUROLOGY, 2019, 86 (01) : 42 - 54
  • [7] Toxicities and Response Rates of Secondary CNS Lymphoma After Adoptive Immunotherapy With CD19-Directed Chimeric Antigen Receptor T Cells
    Karschnia, Philipp
    Rejeski, Kai
    Winkelmann, Michael
    Schoeberl, Florian
    Buecklein, Veit L.
    Blumenberg, Viktoria
    Schmidt, Christian
    Blobner, Jens
    von Bergwelt-Baildon, Michael
    Tonn, Joerg-Christian
    Kunz, Wolfgang G.
    Subklewe, Marion
    von Baumgarten, Louisa
    NEUROLOGY, 2022, 98 (21) : 884 - 889
  • [8] CD19-directed chimeric antigen receptor T-cell therapy: what can we learn from the haematologist?
    Kuipers, Maria Theresa
    Kersten, Marie Jose
    LUPUS SCIENCE & MEDICINE, 2025, 12 (01):
  • [9] Updated insights on cardiac risks of CD19-directed chimeric antigen receptor T-cell therapy: a pharmacovigilance study
    Zhai, Yinghong
    Hu, Fangyuan
    Zhu, Borui
    Xu, Jinfang
    Guo, Xiaojing
    Shi, Wentao
    Zhou, Xiang
    Zheng, Yi
    Xu, Xiao
    Ye, Xiaofei
    He, Jia
    Xu, Feng
    IMMUNOTHERAPY, 2023, 15 (06) : 443 - 456
  • [10] Outcomes of CD19-Directed Chimeric Antigen Receptor T Cell Therapy for Transformed Nonfollicular Lymphoma
    Dong, Ning
    Lopes-Garcia, Lucia Rubio
    Vinal, David
    Bachmeier, Christina
    Shah, Bijal D.
    Nishihori, Taiga
    Khimani, Farhad
    Davila, Marco L.
    Lazaryan, Aleksandr
    Pinilla-Ibarz, Javier
    Locke, Frederick L.
    Jain, Michael D.
    Chavez, Julio C.
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (06): : 349e1 - 349e8
12345